On a recent episode of the My First Million podcast, host Sam Parr walked listeners through a piece of behavioral finance ...

SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its global Phase 1b/2 clinical trial evaluating ...

At ECO 2026, findings from the ATTAIN-MAINTAIN trial were presented, assessing (orforglipron) for maintaining body weight loss in obese or overweight adults.

Check Horoscope Today for May 15, 2026 to know career growth, business opportunities, money matters and financial predictions ...